Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: A randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6

Fertility and Sterility

Volumn 100, Issue 3, 2013, Pages 867-874

  Hamdine, Ouijdane ^a   Broekmans, Frank J ^a   Eijkemans, Marinus J C ^a   Lambalk, Cornelis B ^b,c   Fauser, Bart C J M ^a   Laven, Joop S E ^d   Macklon, Nick S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

GnRH antagonist; IVF; LH estradiol progesterone

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE RETRIEVAL; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; UNIVERSITY HOSPITAL;

ESTRADIOL; GNRH ANTAGONIST; IVF; LH; PROGESTERONE;

ADULT; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; ENDOCRINE SYSTEM; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MALE; MENSTRUAL CYCLE; OVULATION INDUCTION; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84883462968     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.05.031     Document Type: Article

References (41)

1. N.S. Macklon, R.L. Stouffer, L.C. Giudice, and B.C. Fauser The science behind 25 years of ovarian stimulation for in vitro fertilization Endocrinol Rev 27 2006 170 207
2. M.D. Sterrenburg, S.M. Veltman-Verhulst, M.J. Eijkemans, E.G. Hughes, N.S. Macklon, and F.J. Broekmans Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis Hum Reprod Update 17 2011 184 196
3. C. Blockeel, M.D. Sterrenburg, F.J. Broekmans, M.J. Eijkemans, J. Smitz, and P. Devroey Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5 J Clin Endocrinol Metab 96 2011 1122 1128
4. I.J. Duijkers, C. Klipping, W.N. Willemsen, D. Krone, E. Schneider, and G. Niebch Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers Hum Reprod 13 1998 2392 2398
5. Ganirelix Dose-finding Study Group A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group Hum Reprod 13 1998 3023 3031
6. E.M. Kolibianakis, C.A. Venetis, L. Kalogeropoulou, E. Papanikolaou, and B.C. Tarlatzis Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial Fertil Steril 95 2011 558 562
7. H. Al-Inany, M.A. Aboulghar, R.T. Mansour, and G.I. Serour Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol Reprod Biomed Online 10 2005 567 570
8. J.A. Huirne, R. Homburg, and C.B. Lambalk Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 22 2007 2805 2813
9. J.A. Huirne, A.C. van Loenen, R. Schats, J. McDonnell, P.G. Hompes, and J. Schoemaker Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy Hum Reprod 20 2005 359 367
10. E. Kolibianakis, C. Bourgain, C. Albano, K. Osmanagaoglu, J. Smitz, and Steirteghem A. Van Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up Fertil Steril 78 2002 1025 1029
11. E.M. Kolibianakis, C. Albano, J. Kahn, M. Camus, H. Tournaye, and A.C. Van Steirteghem Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy Fertil Steril 79 2003 873 880
12. E.M. Kolibianakis, K. Zikopoulos, J. Schiettecatte, J. Smitz, H. Tournaye, and M. Camus Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF Hum Reprod 19 2004 2490 2496
13. E. Bosch, E. Escudero, J. Crespo, C. Simon, J. Remohi, and A. Pellicer Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome Fertil Steril 84 2005 1529 1532
14. K. Doody, P. Devroey, K. Gordon, H. Witjes, and B. Mannaerts LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles Reprod Biomed Online 20 2010 565 567
15. G. Griesinger, D.B. Shapiro, E.M. Kolibianakis, H. Witjes, and B.M. Mannaerts No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH Reprod Biomed Online 23 2011 457 465
16. E.M. Kolibianakis, J. Collins, B. Tarlatzis, E. Papanikolaou, and P. Devroey Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review Hum Reprod Update 12 2006 3 12
17. P. Merviel, J.M. Antoine, E. Mathieu, F. Millot, J. Mandelbaum, and S. Uzan Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer Fertil Steril 82 2004 119 125
18. G.S. Basir, W.S. O, E.H. Ng, and P.C. Ho Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation Hum Reprod 16 2001 435 440
19. D. Valbuena, J. Martin, J.L. de Pablo, J. Remohi, A. Pellicer, and C. Simon Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo Fertil Steril 76 2001 962 968
20. D. Kyrou, B. Popovic-Todorovic, H.M. Fatemi, C. Bourgain, P. Haentjens, and Landuyt L. Van Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum Reprod 24 2009 2902 2909
21. The European and Middle East Orgalutran Study Group Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum Reprod 16 2001 644 651
22. L. Detti, F.D. Yelian, M.L. Kruger, M.P. Diamond, A. Rode, and M.F. Mitwally Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist Fertil Steril 89 2008 998 1001
23. E. Bosch, I. Valencia, E. Escudero, J. Crespo, C. Simon, and J. Remohi Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Fertil Steril 80 2003 1444 1449
24. E. Bosch, E. Labarta, J. Crespo, C. Simon, J. Remohi, and J. Jenkins Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles Hum Reprod 25 2010 2092 2100
25. E.M. Kolibianakis, C. Albano, M. Camus, H. Tournaye, A.C. Van Steirteghem, and P. Devroey Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists Fertil Steril 82 2004 102 107
26. E.M. Kolibianakis, C.A. Venetis, J. Bontis, and B.C. Tarlatzis Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis Curr Pharm Biotechnol 13 2012 464 470
27. D. Kyrou, E.M. Kolibianakis, H.M. Fatemi, M. Camus, H. Tournaye, and B.C. Tarlatzis High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection Fertil Steril 96 2011 884 888
28. D. Kyrou, M. Al-Azemi, E.G. Papanikolaou, P. Donoso, K. Tziomalos, and P. Devroey The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles Eur J Obstet Gynecol Reprod Biol 162 2012 165 168
29. E.G. Papanikolaou, E.M. Kolibianakis, C. Pozzobon, P. Tank, H. Tournaye, and C. Bourgain Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer Fertil Steril 91 2009 949 952
30. E.G. Papanikolaou, G. Pados, G. Grimbizis, E. Bili, L. Kyriazi, and N.P. Polyzos GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study Hum Reprod 27 2012 1822 1828
31. E.M. Kolibianakis, C. Albano, M. Camus, H. Tournaye, A.C. Van Steirteghem, and P. Devroey Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles J Clin Endocrinol Metab 88 2003 5632 5637
32. J.J. Oberye, B.M. Mannaerts, J.A. Huisman, and C.J. Timmer Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers Fertil Steril 72 1999 1006 1012
33. H.L. Fevold Synergism of the follicle stimulating luteinizing hormones in producing estrogen secretion Endocrinology 28 1941 33 36
34. I.E. Messinis, D. Loutradis, E. Domali, C.P. Kotsovassilis, L. Papastergiopoulou, and A. Kallitsaris Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment Hum Reprod 20 2005 3192 3197
35. I.E. Messinis, P. Vanakara, A. Zavos, C. Verikouki, P. Georgoulias, and K. Dafopoulos Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women Fertil Steril 94 2010 1554 1556
36. E.M. Kolibianakis, K. Zikopoulos, J. Smitz, M. Camus, H. Tournaye, and A.C. Van Steirteghem Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists Hum Reprod 19 2004 1525 1529
37. C. Blockeel, M. Baumgarten, Vos M. De, G. Verheyen, and P. Devroey Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study Curr Pharm Biotechnol 12 2011 423 428
38. T. Lainas, J. Zorzovilis, G. Petsas, G. Stavropoulou, H. Cazlaris, and V. Daskalaki In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF Hum Reprod 20 2005 2426 2433
39. K. Jayaprakasan, J. Hopkisson, B. Campbell, I. Johnson, J. Thornton, and N. Raine-Fenning A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count BJOG 117 2010 853 862
40. L.M. Kettel, S.J. Roseff, T.C. Chiu, M.L. Bangah, W. Vale, and J. Rivier Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition J Clin Endocrinol Metab 73 1991 644 649
41. M.F. Verberg, M.J. Eijkemans, N.S. Macklon, E.M. Heijnen, E.B. Baart, and F.P. Hohmann The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis Hum Reprod Update 15 2009 5 12